Please join the PKD Atlanta Chapter as we welcome Dr. Rahbari-Oskoui, MD, MS, FASN to discuss JYNARQUE™ (Tolvaptan), clinical trials and new discoveries in PKD.

*The U.S. Food and Drug Administration (FDA) granted approval of JYNARQUE™ to be the first treatment in the United States for adult patients with autosomal dominant polycystic kidney disease (ADPKD).

Speaker: Dr. Rahbari-Oskoui, MD, MS, FASN
Dr. Rahbari Oskoui graduated from the Université De Bordeaux li, U.e.r. De Med, Bordeaux, France in 1997. He works in Atlanta, GA and specializes in Nephrology and Internal Medicine at Emory University School of Medicine

Saturday, August 11, 2018
10:00 – 11:30 AM

Weber Shandwick
944 Brady Ave NW @ 10th Street
Atlanta, GA 30318